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Available online 13 September 2016 We have generated a human induced pluripotent stem cell (iPSC) line derived from urinary cells of a 28 year old healthy female donor. The cells were reprogrammed using a non-integrating viral vector and have shown full differentiation potential. Together with the iPSC line, the donor provided blood cells for the study of immunological effects of the iPSC line and its derivatives in autologous and allogeneic settings. The line is available and registered in the human pluripotent stem cell registry as BCRTi005-A. 
Material and methods

Ethical statement
This work was approved by the Ethics Commission of the Charité -Universitätsmedizin Berlin (EA4/110/10).
Urinary cell isolation and expansion
Urine was obtained from a female healthy Caucasian donor of 28 years of age. Urinary cells were isolated according to the protocol described by Zhou et al. (2012) . After centrifugation and washing with PBS (Gibco) the obtained cell pellet was resuspended in primarymedium containing DMEM high glucose (GIBCO) and HAM's F12 (Biochrom), which were mixed in a 1:1 ratio and supplemented with 2,5 μg/ml amphotericin B (Biochrom), 10% (v/v) fetal bovine serum (FBS, Biochrom), penicillin/streptomycin (P/S, 100 U/ml/100 μg/ml, Biochrom) and the renal growth media (REGM) SingleQuot kit (Lonza) and finally plated on 0,1% w/t gelatin coated (Milipore) plates. Primary-medium was added for the following three days and afterwards successively changed to proliferation-medium which was a 1:1 mixture of DMEM high glucose and the REBM basal medium supplemented with 5% (v/v) FBS, 1,25 mM GlutaMax™ , 0,5% (v/v) nonessential amino acids (NEAA, Gibco), P/S (50 U/ml, 50 μg/ml), 2,5 ng/ml basic fibroblast growth factor (bFGF), 2,5 ng/ml platelet derived growth factor (PDGF-AB), 2,5 ng/ml human epidermal 
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Stem Cell Research j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / s c r growth factor (hEGF, all Peprotech) and the REGM SingleQuot kit. First colonies appeared on day 5. After reaching about 90% confluency, cells were passaged using trypsin (Biochrom) and replated on gelatin coated dishes in a ratio of 1:10. Cells were frozen in FBS containing 10% dimethylsulfoxid (DMSO).
Reprogramming and hiPSC maintenance
Urinary cells were thawed and cultivated in RPMI (Gibco) medium supplemented with 10% FBS and 1% P/S on gelatin coated dishes until reaching confluence of around 90% again. The Sendai virus (SeV) based non-integration CytoTune™ iPS Reprogramming Kit (Life Technologies) (Fusaki et al., 2009 ) was used according to manufacturer's instructions. First colonies appeared after 10 days. 5 single colonies were picked and cultivated under feeder free conditions on Geltrex (Life Technologies) in TeSR-E8 medium (Stemcell Technologies) supplemented with 1% P/S. The hiPSCs were passaged every 5-7 days in a ratio of 1:6. At passage 14, colonies were tested for virus loss and pluripotency marker expression and one of the 5 colonies was kept in culture for further analysis. Frozen stocks of the other colonies were kept too. Pluripotency marker staining of hiPSCs hiPSCs were fixed (BD Cytofix) and permeabilized using Perm/Wash buffer (BD) and stained with antibodies against the pluripotency markers TRA-1-60 (Novous Biologicals), TRA-1-81 (Novus Biologicals), OCT-4 PerCP-Cy5.5 (BD) and SSEA-4 FITC (R&D). Subsequently, cell nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen). The final analysis was performed using the High Content Screening Imaging System Operetta (Perkin Elmer).
RNA isolation and cDNA synthesis
Total RNA was extracted (Qiagen RNA Mini Kit) and transcribed into cDNA using the SuperScript® III Transcriptase Kit (Life Technologies).
Detection of SeV genome and transgenes
After 14 passages, hiPSC lines were tested for SeV residues. PCR was performed using primers and instructions (Table 1) as recommended by the manufacturer. As positive control RNA was used from the reprogramming leftovers. Negative control RNA was obtained from the hiPSC line WISCi004-A (IMR90, WiCell), which was lentivirally reprogrammed from IRM90.4 fibroblasts.
Embryoid body (EB) formation and germ layer differentiation
To test the capacity of the reprogrammed hiPSC line to spontaneously differentiate into cells of all three germ layers, hiPSCs were harvested using accutase (Gibco) and seeded in TeSR-E8 supplemented with 10 μm Rock inhibitor (StemCell Technologies) into AggreWell plates 800 (StemCell Technologies). EBs formed within 24 h and were further cultivated on ultra-low attachment plates (Corning) in KO-DMEM (Invitrogen) supplemented with 20% Knockout SerumReplacer (Invitrogen), 1,25 mM GlutaMax™, 1% (v/v) NEAA, 0,2% (v/v) betaMercaptoethanol (Gibco) and P/S (100 U/ml/100 μg/ml) for 10 days. Medium was changed every 48 h.
EBs were harvested and isolated RNA was transcribed into cDNA. PCR was performed to analyze the expression of germ layer specific genes ( Table 2 ). The following PCR program was used: 96°C for 
Karyogram
For the detection of chromosomal aberrations, the KaryoLite™ BoBs™ Kit was used supplied by Perkin Elmer (Lund et al., 2012) . Genomic DNA was processed according to the manufacturer's instructions. Female and male controls were used in parallel. The fluorescent signal was detected using the Bio-Plex 200 system (BioRad) and finally analyzed using the Perkin Elmer software BoBsoft™.
Fingerprinting
Short Tandem Repeat (STR) analysis was performed to identify the purity of these cell lines. DNA was extracted (Qiagen) from the hiPSCs and the corresponding primary cells. The genome was analyzed for 10 different loci out of the Combined DNA Index System (CODIS):
